1
Views
5
CrossRef citations to date
0
Altmetric
Gene Expression

A Phorbol Ester-Regulated Ribonuclease System Controlling Transforming Growth Factor β1 Gene Expression in Hematopoietic Cells

&
Pages 5983-5990 | Received 12 Apr 1990, Accepted 22 Aug 1990, Published online: 31 Mar 2023

Literature Cited

  • Akhurst, R. J., F. Fee, and A. Balmain. 1988. Localized production of TGF-β mRNA in tumour promoter-stimulated mouse epidermis. Nature (London) 331:363-365.
  • Alitalo, R., L. C. Andersson, C. Betsholtz, K. Nilsson, B. Westermark, C.-H. Heldin, and K. Alitalo. 1987. Induction of platelet-derived growth factor gene expression during mega- karyoblastic and monocytic differentiation of human leukemia cell lines. EMBO J. 6:1213-1218.
  • Alitalo, R., T. P. Mäkelä, P. Koskinen, L. C. Andersson, and K. Alitalo. 1988. Enhanced expression of transforming growth factor β during megakaryoblastic differentiation of K562 leukemia cells. Blood 71:899-906.
  • Angel, P., K. Hattori, T. Smeal, and M. Karin. 1988. The jun proto-oncogene is positively autoregulated by its product, Jun/ AP-1. Cell 55:875-885.
  • Angel, P., M. Imagawa, R. Chiu, B. Stein, R. J. Imbra, H. J. Rahmsdorf, C. Jonat, P. Herrlich, and M. Karin. 1987. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729-739.
  • Assoian, R. K., B. E. Fleurdelys, H. C. Stevenson, P. J. Miller, D. K. Madtes, E. W. Raines, R. Ross, and M. B. Sporn. 1987. Expression and secretion of type β transforming growth factor by activated human macrophages. Proc. Natl. Acad. Sci. USA 84:6020-6024.
  • Assoian, R. K., G. R. Grotendorst, D. M. Miller, and M. B. Sporn. 1984. Cellular transformation by coordinated action of three peptide growth factors from human platelets. Nature (London) 309:804-806.
  • Assoian, R. K., A. Komoriya, C. A. Meyers, D. M. Miller, and M. B. Sporn. 1983. Transforming growth factor-β in human platelets: identification of a major storage site, purification, and characterization. J. Biol. Chem. 258:7155-7160.
  • Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1987. Current protocols in molecular biology. John Wiley & Sons, Inc., New York.
  • Barnard, E. A. 1969. Ribonucleases. Annu. Rev. Biochem. 38:677-732.
  • Bascom, C. C., J. R. Wolfshohl, R. J. Coffey, Jr., L. Madisen, N. R. Webb, A. R. Purchio, R. Derynck, and H. L. Moses. 1989. Complex regulation of transforming growth factor β1, β2, and β3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors β1 and β2. Mol. Cell. Biol. 9:5508-5515.
  • Blanchard, J.-M., M. Piechaczyk, C. Dani, J.-C. Chambard, A. Franchi, J. Pouyssegur, and P. Jeanteur. 1985. c-myc gene is transcribed at high rate in G°-arrested fibroblasts and is post- transcriptionally regulated in response to growth factors. Nature (London) 317:443-445.
  • Brawerman, G. 1987. Determinants of messenger RNA stability. Cell 48:5-6.
  • Brawerman, G. 1989. mRNA decay: finding the right targets. Cell 57:9-10.
  • Brewer, G., and J. Ross. 1988. Poly(A) shortening and degradation of the 3′ A+U-rich sequences of human c-myc mRNA in a cell-free system. Mol. Cell. Biol. 8:1697-1708.
  • Coffey, R. J., Jr., C. C. Bascom, N. J. Sipes, R. Graves-Deal, B. E. Weissman, and H. L. Moses. 1988. Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor p. Mol. Cell. Biol. 8:3088-3093.
  • Dani, C.-H., N. Mechti, M. Piechaczyk, B. Lebleu, P.-H. Jeanteur, and J.-M. Blanchard. 1985. Increased rate of degradation of c-myc mRNA in interferon-treated Daudi cells. Proc. Natl. Acad. Sci. USA 82:4896-4899.
  • DeLisle, A. J., R. A. Graves, W. F. Marzluff, and L. F. Johnson. 1983. Regulation of histone mRNA production and stability in serum-stimulated mouse 3T6 fibroblasts. Mol. Cell. Biol. 3:1920-1929.
  • Derynck, R., J. A. Jarrett, E. Y. Chen, D. H. Eaton, J. R. Bell, R. K. Assoian, A. B. Roberts, M. B. Sporn, and D. V. Goeddel. 1985. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature (London) 316:701-705.
  • Derynck, R., L. Rhee, E. Y. Chen, and A. Van Tilburg. 1987. Intron-exon structure of the human transforming growth factor-β precursor gene. Nucleic Acids Res. 15:3188-3189.
  • Eick, D., M. Piechaczyk, B. Henglein, J.-M. Blanchard, B. Traub, E. Kofler, S. Wiest, G. M. Lenoir, and G. W. Bornkamm. 1985. Aberrant c-myc RNAs of Burkitt’s lymphoma cells have longer half-lives. EMBO J. 4:3717-3725.
  • Ernst, T. J., A. R. Ritchie, G. D. Demetri, and J. D. Griffin. 1989. Regulation of granulocyte- and monocyte-colony stimulating factor mRNA levels in human blood monocytes is mediated primarily at a post-transcriptional level. J. Biol. Chem. 264:5700-5703.
  • Fort, P.-H., L. Marty, M. Piechaczyk, S. El Sabrouty, C.-H. Dani, P.-H. Jeanteur, and J.-M. Blanchard. 1985. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 13:1431-1442.
  • Jones, T. R., and M. D. Cole. 1987. Rapid cytoplasmic turnover of c-myc mRNA: requirement of the 3′ untranslated sequences. Mol. Cell. Biol. 7:4513-4521.
  • Kabnick, K. S., and D. E. Housman. 1988. Determinants that contribute to cytoplasmic stability of human c-fos and β-globin mRNAs are located at several sites in each mRNA. Mol. Cell. Biol. 8:3244-3250.
  • Kehrl, J. H., A. B. Roberts, L. M. Wakefield, S. B. Jakowlew, M. B. Sporn, and A. S. Fauci. 1986. Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes. J. Immunol. 137:3855-3860.
  • Kehrl, J. H., L. M. Wakefield, A. B. Roberts, S. Jakowlew, M. Alvarez-Mon, R. Derynck, M. B. Sporn, and A. S. Fauci. 1986. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163:1037-1050.
  • Kim, S.-J., F. Denhez, K. Y. Kim, J. T. Holt, M. B. Sporn, and A. B. Roberts. 1989. Activation of the second promoter of the transforming growth factor-β1 gene by transforming growth factor-β1 and phorbol ester occurs through the same target sequences. J. Biol. Chem. 264:19373-19378.
  • Kim, S.-J., A. Glick, M. B. Sporn, and A. B. Roberts. 1989. Characterization of the promoter region of the human transforming growth factor-β1 gene. J. Biol. Chem. 264:402-408.
  • Kim, S.-J., K.-T. Jeang, A. B. Glick, M. B. Sporn, and A. B. Roberts. 1989. Promoter sequences of the human transforming growth factor-β1 gene responsive to transforming growth factor-β1 autoinduction. J. Biol. Chem. 264:7041-7045.
  • Knight, E., Jr., E. D. Anton, D. Fahey, B. K. Friedland, and G. J. Jonak. 1985. Interferon regulates c-myc gene expression in Daudi cells at the post-transcriptional level. Proc. Natl. Acad. Sci. USA 82:1151-1154.
  • Koeller, D. M., J. L. Casey, M. W. Hentze, E. M. Gerhardt, L.-N. L. Chan, R. D. Klausner, and J. B. Harford. 1989. A cytosolic protein binds to structural elements within the iron regulatory region of the transferrin receptor mRNA. Proc. Natl. Acad. Sci. USA 86:3574-3578.
  • Kondaiah, P., E. Van Obberghen-Schilling, R. L. Ludwig, R. Dhar, M. B. Sporn, and A. B. Roberts. 1988. cDNA cloning of porcine transforming growth factor-β1 mRNAs. J. Biol. Chem. 263:18313-18317.
  • Lamph, W. W., P. Wamsley, P. Sassone-Corsi, and I. M. Verma. 1988. Induction of proto-oncogene JUN/AP-1 by serum and TPA. Nature (London) 334:629-631.
  • Malter, J. S. 1989. Identification of an AUUUA-specific messenger RNA binding protein. Science 246:664-666.
  • Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
  • Massague, J., S. Cheifetz, T. Endo, and B. Nadal-Ginard. 1986. Type β transforming growth factor is an inhibitor of myogenic differentiation. Proc. Natl. Acad. Sci. USA 83:8206-8210.
  • Mattia, E., J. Den Blaauwen, G. Ashwell, and J. Van Renswoude. 1989. Multiple post-transcriptional regulatory mechanisms in ferritin gene expression. Proc. Natl. Acad. Sci. USA 86:1801-1805.
  • Miller, A. D., T. Curran, and I. M. Verma. 1984. c-fos protein can induce cellular transformation: a novel mechanism of activation of a cellular oncogene. Cell 36:51-60.
  • Milliner, E. W., and L. C. Kühn. 1988. A stem-loop in the 3′ untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm. Cell 53:815-825.
  • Müllner, E. W., B. Neupert, and L. C. Kühn. 1989. A specific mRNA binding factor regulates the iron-dependent stability of cytoplasmic transferrin receptor mRNA. Cell 58:373-382.
  • Ohta, M., J. S. Greenberger, P. Anklesaria, A. Bassols, and J. Massague. 1987. Two forms of transforming growth factor-βdistinguished by multipotential hematopoietic progenitor cells. Nature (London) 329:539-541.
  • Pachter, J. S., T. J. Yen, and D. W. Cleveland. 1987. Autoregulation of tubulin expression is achieved through specific degradation of polysomal tubulin mRNAs. Cell 51:283-292.
  • Pandey, N. B., and W. F. Marzluff. 1987. The stem-loop structure at the 3′ end of histone mRNA is necessary and sufficient for regulation of histone mRNA stability. Mol. Cell. Biol. 7:4557-4559.
  • Pei, R., and K. Calame. 1988. Differential stability of c-myc mRNAs in a cell-free system. Mol. Cell. Biol. 8:2860-2868.
  • Peltz, S. W., G. Brewer, G. Kobs, and J. Ross. 1987. Substrate specificity of the exonuclease activity that degrades H4 histone mRNA. J. Biol. Chem. 262:9382-9388.
  • Rahmsdorf, H. J., A. Schönthal, P. Angel, M. Litfin, U. Rüther, and P. Herrlich. 1987. Post-transcriptional regulation of c-fos mRNA expression. Nucleic Acids Res. 15:1643-1659.
  • Ralph, P., N. Williams, M. A. S. Moore, and P. B. Litcofsky. 1982. Induction of antibody-dependent and nonspecific tumor killing in human monocytic leukemia cells by nonlymphocyte factors and phorbol ester. Cell Immunol. 71:215-223.
  • Roberts, A. B., M. A. Anzano, L. M. Wakefield, N. S. Roche, D. F. Stern, and M. B. Sporn. 1985. Type βtransforming growth factor: a bifunctional regulator of cellular growth. Proc. Natl. Acad. Sci. USA 82:119-123.
  • Rook, A. H., J. H. Kehrl, L. M. Wakefield, A. B. Roberts, M. B. Sporn, D. B. Burlington, H. C. Lane, and A. S. Fauci. 1986. Effects of transforming growth factor βon the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J. Immunol. 136:3916-3920.
  • Ross, J., and G. Kobs. 1986. H4 histone messenger RNA decay in cell-free extracts initiates at or near the 3′ terminus and proceeds 3′ to 5′. J. Mol. Biol. 188:579-593.
  • Ross, J., G. Kobs, G. Brewer, and S. W. Peltz. 1987. Properties of the exonuclease activity that degrades H4 histone mRNA. J. Biol. Chem. 262:9374-9381.
  • Ross, R., E. W. Raines, and D. F. Bowen-Pope. 1986. The biology of platelet-derived growth factor. Cell 46:155-169.
  • Saha, B. K., M. Y. Graham, and D. Schlessinger. 1979. Acid ribonuclease from HeLa cell lysosomes. J. Biol. Chem. 254:5951-5957.
  • Schuler, G. D., and M. D. Cole. 1988. GM-CSF and oncogene mRNA stabilities are independently regulated in trans in a mouse monocytic tumor. Cell 55:1115-1122.
  • Scotto, L., P. I. Vaduva, R. E. Wager, and R. K. Assoian. 1990. Type β1 transforming growth factor gene expression: a corrected mRNA structure reveals a downstream phorbol ester responsive element in human cells. J. Biol. Chem. 265:2203-2208.
  • Shaw, G., and R. Kamen. 1986. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659-667.
  • Shipley, G. D., R. F. Tucker, and H. L. Moses. 1985. Type β transforming growth factor/growth inhibitor stimulates entry of monolayer cultures of AKR-2B cells into S phase after a prolonged prereplicative interval. Proc. Natl. Acad. Sci. USA 82:4147-4151.
  • Shyu, A.-B., M. E. Greenberg, and J. G. Belasco. 1989. The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. Genes Dev. 3:60-72.
  • Sittman, D. B., R. A. Graves, and W. F. Marzluff. 1983. Histone mRNA concentrations are regulated at the level of transcription and mRNA degradation. Proc. Natl. Acad. Sci. USA 80:1849-1853.
  • Sporn, M. B., A. B. Roberts, L. M. Wakefield, and B. de Crombrugghe. 1987. Some recent advances in the chemistry and biology of transforming growth factor-β. J. Cell Biol. 105:1039-1045.
  • Sunitha, I., and L. I. Slobin. 1987. An in vitro system derived from Friend erythroleukemia cells to study messenger RNA stability. Biochem. Biophys. Res. Commun. 144:560-568.
  • Tucker, R. F., G. D. Shipley, H. L. Moses, and R. W. Holley. 1984. Growth inhibitor from BSC-1 cells closely related to platelet type β transforming growth factor. Science 226:705-707.
  • Van Obberghen-Schilling, E., N. S. Roche, K. C. Flanders, M. B. Sporn, and A. B. Roberts. 1988. Transforming growth factor β1 positively regulates its own expression in normal and transformed cells. J. Biol. Chem. 263:7741-7746.
  • Wahl, S. M., D. A. Hunt, L. M. Wakefield, N. McCartney-Francis, L. M. Wahl, A. B. Roberts, and M. B. Sporn. 1987. Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA 84:5788-5792.
  • Weber, B., J. Horiguchi, R. Luebbers, M. Sherman, and D. Kufe. 1989. Post-transcriptional stabilization of c-fms mRNA by a labile protein during human monocytic differentiation. Mol. Cell. Biol. 9:769-775.
  • Wodnar-Filipowicz, A., and C. Moroni. 1990. Regulation of interleukin 3 mRNA expression in mast cells occurs at the posttranscriptional level and is mediated by calcium ions. Proc. Natl. Acad. Sci. USA 87:777-781.
  • Yamato, K., Z. El-Hajjaoui, and H. P. Koeffler. 1989. Regulation of levels of IL-1 mRNA in human fibroblasts. J. Cell. Physiol. 139:610-616.
  • Yen, T. J., D. A. Gay, J. S. Pachter, and D. W. Cleveland. 1988. Autoregulated changes in stability of polyribosome-bound β-tubulin mRNAs are specified by the first 13 translated nucleotides. Mol. Cell. Biol. 8:1224-1235.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.